Zimmer Biomet Holdings (ZBH) Cash from Investing Activities Growth (3y) (2012 - 2026)
Zimmer Biomet Holdings (ZBH) Cash from Investing Activities Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.93 Bn | 193.33 Bn | 7.27 Bn | 17.83% |
| 2 | Stryker | 128.56 Bn | 125.08 Bn | 4.50 Bn | -6.23% |
| 3 | Medtronic | 119.26 Bn | 110.04 Bn | 6.41 Bn | -24.52% |
| 4 | Boston Scientific | 73.35 Bn | 72.81 Bn | 3.85 Bn | -32.54% |
| 5 | Edwards Lifesciences | 52.06 Bn | 47.81 Bn | 1.35 Bn | -68.12% |
| 6 | Dexcom | 34.55 Bn | 32.61 Bn | 830.00 Mn | 37.39% |
| 7 | GE HealthCare Technologies | 34.05 Bn | 31.94 Bn | 2.18 Bn | -11.04% |
| 8 | Koninklijke Philips | 26.39 Bn | 23.07 Bn | 4.55 Bn | 19.58% |
| 9 | Steris | 23.15 Bn | 22.67 Bn | 684.20 Mn | -17.67% |
| 10 | Zimmer Biomet Holdings | 19.31 Bn | 18.90 Bn | 1.54 Bn | 7.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 7.76% |
| Mar 31, 2026 | -2.10% |
| Dec 31, 2025 | -41.98% |
| Sep 30, 2025 | -24.22% |
| Jun 30, 2025 | -78.55% |
| Mar 31, 2025 | -9.34% |
| Dec 31, 2024 | -32.92% |
| Sep 30, 2024 | -11.32% |
| Jun 30, 2024 | -35.68% |
| Mar 31, 2024 | -21.73% |
| Dec 31, 2023 | 6.07% |
| Sep 30, 2023 | -21.91% |
| Jun 30, 2023 | -41.78% |
| Mar 31, 2023 | -7.22% |
| Dec 31, 2022 | 6.58% |
| Sep 30, 2022 | 19.55% |
| Jun 30, 2022 | 8.95% |
| Mar 31, 2022 | 8.39% |
| Dec 31, 2021 | -14.59% |
| Sep 30, 2021 | 6.84% |